Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients.All patients experienced stabilization of Expanded Disability ...

Broad rim lesions, which have wider rims of immune cells, are associated with faster disease progression in MS, per a study.

Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded ...

The research combined PET imaging data from 114 Finnish MS patients with post ... Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis, ...

VTX3232 in Parkinson’s Disease (Q2 2025 data): The Phase 2 open-label biomarker and imaging trial of VTX3232 in patients ... including Alzheimer’s disease, multiple sclerosis, and amyotrophic lateral ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

Gerald Voelbel, 57, a cognitive neuroscientist, awoke with double vision, a migraine, and coordination issues—symptoms that ...